Showing 8,001 - 8,020 results of 48,899 for search '(( a ((mean decrease) OR (linear decrease)) ) OR ( a ((greatest decrease) OR (largest decrease)) ))', query time: 0.90s Refine Results
  1. 8001

    Loss of epithelial markers is an early event in oral dysplasia and is observed within the safety margin of dysplastic and T1 OSCC biopsies by Zahra Abdalla (4669927)

    Published 2017
    “…Therefore, these markers provide a useful means to predict abnormal epithelium in patient biopsies. …”
  2. 8002

    Predictive Modeling of pH in an Aquaponics System Using Bayesian and Non-Bayesian Linear Regression to Inform System Maintenance by Jameson Mori (11236882)

    Published 2021
    “…These systems can be a good source of fresh food but must maintain a delicate balance between the water quality requirements of the fish, plants, and nitrifying bacteria or risk decreased production, disease, and death. …”
  3. 8003

    Decreased Sho levels correlate with the amount of PrP<sup>Sc</sup> C2 fragment present in prion-infected animals. by Joel C. Watts (195735)

    Published 2011
    “…Infection with RML prions resulted in the largest decrease in Sho levels and the highest amount of PrP<sup>Sc</sup> C2 fragment (determined after digestion with thermolysin (TL) and PNGaseF). …”
  4. 8004
  5. 8005
  6. 8006

    Connectivity between the left nucleus accumbens and two clusters. by Karel Joineau (21799908)

    Published 2025
    “…After intervention there was a significant decrease in the FR group (mean at V1: 0.249 ± 0.094, mean at V5: 0.130 ± 0.101, difference: −0.119 ± 0.097, p < 0.001) and a significant increase in the SM group (mean at V1: 0.156 ± 0.113, mean at V5: 0.287 ± 0.107, difference: 0.131 ± 0.066, p < 0.001). …”
  7. 8007

    Patterns of lifetime use of substances by gender. by Daniel Waiganjo Kinyanjui (15877725)

    Published 2023
    “…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”
  8. 8008

    S1 Data - by Daniel Waiganjo Kinyanjui (15877725)

    Published 2023
    “…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”
  9. 8009

    Factors associated with substance use. by Daniel Waiganjo Kinyanjui (15877725)

    Published 2023
    “…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”
  10. 8010

    Factors associated with personality traits. by Daniel Waiganjo Kinyanjui (15877725)

    Published 2023
    “…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”
  11. 8011
  12. 8012
  13. 8013

    Data supporting this article. by Karel Joineau (21799908)

    Published 2025
    “…Clinical variables did not significantly differed between FR and SM groups. Mean VAS decreased by −12.3 mm ± 15.2 in FR group (n = 15) and −17.9 mm ± 29.4 in SM group (n = 15). …”
  14. 8014

    Demographic and clinical data at baseline. by Karel Joineau (21799908)

    Published 2025
    “…Clinical variables did not significantly differed between FR and SM groups. Mean VAS decreased by −12.3 mm ± 15.2 in FR group (n = 15) and −17.9 mm ± 29.4 in SM group (n = 15). …”
  15. 8015

    Changes in clinical variables. by Karel Joineau (21799908)

    Published 2025
    “…Clinical variables did not significantly differed between FR and SM groups. Mean VAS decreased by −12.3 mm ± 15.2 in FR group (n = 15) and −17.9 mm ± 29.4 in SM group (n = 15). …”
  16. 8016
  17. 8017
  18. 8018
  19. 8019
  20. 8020

    Mean ± SEM FPKM values measured for differentially expressed genes. by Sarah W. Keenan (765990)

    Published 2015
    “…Several genes were abbreviated for simplicity: “PPBP,PF4,CXCL” includes Ppbp/Pf4/Cxcl1/Pf4v1/ Cxcl6/ Cxcl3/ Cxcl5/ Cxcl2/ Il8/ Cxcl10/ Cxc11; “CLK,PPIL3” includes Clk3/Ppil3/Clk1/Clk4). The mean FPKM values, P-values, sequence length, and exon density for each of these genes can be found in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0131669#pone.0131669.s005" target="_blank">S1</a>–<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0131669#pone.0131669.s007" target="_blank">S3</a> Tables.…”